Morten Snede

Morten Snede brings more than 20 years of experience from various senior level managerial positions in the financial- and cannabis industry as both a CFO and Group Director. In 2018 Morten joined Canopy Growth as Managing Director (Denmark) tasked with the establishment and development of the largest facility in Denmark. In 2021 Canopy Growth’s Danish operations was sold to Little Green Pharma, where Morten continued. As per October 24th 2022 Morten joined Medican as group CEO. Mortens is also former Chairman of the Board of the Medical Cannabis Industry Association in Denmark.


CEO Morten Brandt

Morten is internationally experienced as an Executive in Healthcare. He has 15 years of experience in pharmaceutical GM roles. He has vast international experience within distributor management, pharma- and cannabis industry.

Ivan Hribar

Ivan Hribar (Ivo) has 30+ years’ experience within finance management, setting up finance and controlling organizations and business partnering. Ivo has held Finance Management positions in several international logistic and transport companies such as DB Schenker, DSV and Scan Global Logistics.
Ivo holds HD(R) in accounting and finance from Copenhagen Business School.

Lilly Krogsgaard
Director of Regulatory Affairs

Lilly has been working in a political environment both as employee and as appointed to committees and working parties on difference issues as law preparation, reimbursement, drug information, patient safety. Specialised in Regulatory Affairs, Quality Assurance, Experience in Pharmaceutical Products and Medical Devices, Compliance & Processes, GMP / GXP, auditing and with past position with the Danish Medicines Agency, H. Lundbeck A/S, Sandoz A/S and A-Consult.

M.Sc. Pharm Marianne Schwarz
Director of QA/QC/Compliance

Experienced compliance manager QA/QP/QC with 30+ years of experience from major Pharmaceutical companies among here Novartis.